Oncology
HR+/HER2- Early Breast Cancer
Expert Perspectives® in HR+/HER2- Early Breast Cancer to Cover Key Topics in HR+/HER2- Early Breast Cancer Treatment
Overview
Expert Perspectives® delivers health care providers with insights from key thought leaders on the latest advancements and current practices in medicine, in a concise and timely format. Expert Perspectives® in HR+/HER2- Early Breast Cancer will feature community-selected experts and topics that we hope you will find of value in your clinical practice.
VIEW THE TOPICS:
Patient Care Perspectives
- Multidisciplinary Management of Patients With Early-Stage HR+/HER2- Breast Cancer
- Surveillance Expectations for Early-Stage Breast Cancer
- Symptom Clusters That Matter to Patients With Early-Stage HR+/HER2- Breast Cancer
Clinical Topic Updates
- Adjuvant CDK4/6 Inhibitors: Who Should Get Them and How to Manage Them
- Multigene Assays and the Management of Early-Stage HR+/HER2- Breast Cancer
- Risk Assessment and Reduction Strategies for Early-Stage HR+/HER2- Breast Cancer
Expert Roundtables
- Expert Roundtable Podcast: Managing Endocrine Therapy-Related Side Effects and Adherence
- Neoadjuvant Therapy for HR+/HER2- Breast Cancer
